logo
Exclusive-Global trading giants step up India presence, fuelling talent rush, exchange upgrades

Exclusive-Global trading giants step up India presence, fuelling talent rush, exchange upgrades

Yahoo19 hours ago

By Jaspreet Kalra and Jayshree P Upadhyay
MUMBAI (Reuters) -Half a dozen global trading giants, from Citadel Securities and IMC Trading to Millennium and Optiver, are ratcheting up their presence in India's booming derivatives markets, fuelling a hiring spree and pushing exchanges to improve technology.
The firms' hiring plans, being reported for the first time, come amid expectations that large domestic consumer and investor bases will help shield India from global turmoil sparked by the trade policies of U.S. President Donald Trump.
The South Asian nation made up nearly 60% of global equity derivative trading volumes of 7.3 billion in April, the Futures Industry Association says, while its regulators say notional turnover of the contracts has grown 48 times since March 2018.
For Western firms, the gold rush is too big to ignore, particularly after U.S. trading firm Jane Street earned $2.34 billion from its India trading strategy last year, some of the firms' executives said.
"We have seen competition increasing both on the trading front, where you see more players going for the same opportunities, and on the job market as well," said Jocelyn Dentand of global high-speed trader IMC Trading.
The firm plans to grow its team by more than 50% by the end of 2026 to stand at more than 150, added Dentand, the managing director of its India unit.
Foreign investors turned buyers of Indian stocks in April and May, purchasing a net $2.8 billion, as they abandoned their previous selling stance from October 2024 to March 2025, prompted by high valuations and slower growth in earnings.
U.S.-based Citadel Securities, a market-making firm founded by well known investor Kenneth Griffin, runs a leaner team of around 10 in India but has ramped up capital allocation to its operations, said a source familiar with its plans.
"In India, we're constantly looking for talent and constantly hiring," said the source, who sought anonymity in the absence of authorisation to speak to the media and declined to give details of the plan.
Hedge fund Millennium is expanding its India desk via Dubai and Singapore, said a source with direct knowledge of the matter, who also sought anonymity on the same grounds.
Millennium declined to comment for the story. Citadel Securities did not respond to an email seeking comment.
Netherlands-based Optiver, which launched India operations in 2024, plans to grow its team to 100 by the end of 2025, a spokesperson said, up from 70 now.
"Optiver is investing ambitiously in India, with a view to expanding to 100 FTEs by year-end and scaling further in the years ahead," the spokesperson added.
Amsterdam-based trading firm Da Vinci and London-based Qube Research and Technologies are also recruiting for quantitative trading roles in India, public postings for jobs show.
RUSH FOR TECH, TALENT
Global trading firms are also looking to expand in India by recruiting aggressively from top domestic universities and poaching from home-grown competitors.
They have hired about 300 people in India in the last two years across the trading, technology, compliance, risk, and legal functions, Hong Kong-based recruiter Aquis Search estimates.
"We foresee a good run for the next few years," said Annpurna Bist, its head of quant and tech.
Intensifying competition has driven up salaries, with even junior traders paid more than double the figure of three years ago, said Bhautik Ambani, head of AlphaGrep Investment Management, one of India's leading quant trading firms.
India's top engineering schools have become the favoured hunting grounds for talent.
"We almost solely hire our traders and software engineers from Indian Institutes of Technology (IITs)," said IMC's Dentand, referring to the country's chain of prestigious engineering schools.
But hiring efforts are now being widened to the universities beyond the IITs, Dentand said.
The influx of global trading firms has opened up opportunities for India's two main exchanges, which are both upgrading their tech infrastructure.
The National Stock Exchange of India (NSE) plans to add 2,000 co-location racks over the next two years while older stalwart the Bombay Stock Exchange (BSE) aims to scale up to 500 by the end of fiscal 2026, from none in March 2024.
Such racks are servers at exchanges that cut trade execution times to microseconds.
"We are a late entrant and need to provide additional value for the unfulfilled demand from high-frequency trading firms and quant firms, amongst others, for co-location racks," said BSE Chief Executive Sundararaman Ramamurthy.
The exchange has spent between 4.5 billion rupees and 5 billion rupees ($52 million to $58 million) on technology in the last two years, he said.
The NSE and regulator the Securities and Exchange Board of India (SEBI) did not respond to queries for the report.
($1=85.9675 rupees)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

U.S. strike on Iran now seen as 62% likely
U.S. strike on Iran now seen as 62% likely

Yahoo

time37 minutes ago

  • Yahoo

U.S. strike on Iran now seen as 62% likely

U.S. strike on Iran now seen as 62% likely originally appeared on TheStreet. With missiles flying between Israel and Iran, markets crashing, and everyone refreshing X every 10 seconds, Polymarket, a crypto prediction platform, might be one of the only places offering some clarity. One of the most-watched markets on Polymarket right now is centered on a sobering question: Will the US launch military action against Iran before June 30, 2025? With tensions soaring in the Middle East, this market has attracted over $6 million in trading volume, making it one of the largest geopolitical prediction markets of the year. Polymarket, which launched in 2020, didn't rise overnight. Its traction skyrocketed in the past year, especially around major political events. In 2024 alone, users wagered over $8 billion on predictions related to elections. As of now, the odds are sitting around 62% for "Yes", indicating traders increasingly believe that U.S. intervention is imminent. According to Polymarket's official rules, the market will resolve to "Yes" if there is a confirmed US military action on Iranian soil, airspace, or maritime territory, or against any Iranian embassies or consulates — between March 31 and June 30, 2025. This must be officially acknowledged by the U.S. government or widely confirmed through credible reporting. Examples include airstrikes, naval actions, or any form of kinetic military engagement. Cyberattacks, economic sanctions, or covert diplomacy won't count. If a qualifying military strike is confirmed before June 30, the market will resolve early, locking in profits for 'Yes' holders and losses for 'No' holders. Missiles are flying, cities are on edge, and the world is holding its breath. Over the past few days, Israel and Iran have been locked in a dangerous tit-for-tat that's escalated fast. It began with Israel launching a pre-emptive airstrike on Iran. In response, Iran vowed the 'largest and most intense missile attack in history' on Israeli soil. Since then, Iran has launched multiple volleys of missiles targeting central and northern Israel, while Israeli air defenses and drones have intercepted several of them. Tel Aviv, Haifa, and even areas near the Natanz nuclear site in Iran have sounded air raid sirens as explosions rocked the region. As tensions spiral, Trump, who left the G7 summit early, is back in Washington, issuing ominous warnings. On Truth Social, he told residents of Tehran to evacuate the city immediately. The New York Times reported that he's considering using the U.S.'s most powerful 'bunker buster' bomb to target Iran's Fordo nuclear facility. Markets are already feeling the heat. Oil prices have spiked, Bitcoin dipped sharply, and investors are rattled. U.S. strike on Iran now seen as 62% likely first appeared on TheStreet on Jun 17, 2025 This story was originally reported by TheStreet on Jun 17, 2025, where it first appeared.

Mira Murati's Thinking Machines Lab closes on $2B at $10B valuation
Mira Murati's Thinking Machines Lab closes on $2B at $10B valuation

TechCrunch

timean hour ago

  • TechCrunch

Mira Murati's Thinking Machines Lab closes on $2B at $10B valuation

In Brief Thinking Machines Lab, the secretive AI startup founded by OpenAI's former chief technology officer Mira Murati, has closed a $2 billion seed round, according to The Financial Times. The deal values the six-month-old startup at $10 billion. The company's work remains unclear. The startup has leveraged Murati's reputation and other high-profile AI researchers who have joined the team to attract investors in what could be the largest seed round in history. According to sources familiar with the deal cited by the FT, Andreessen Horowitz led the round, with participation from Sarah Guo's Conviction Partners. Murati left OpenAI last September after leading the development of some of the company's most prominent AI products, including ChatGPT, DALL-E, and voice mode. Several of her former OpenAI colleagues have joined the new startup, including co-founder John Schulman. Murati is one of a handful of executives who left OpenAI after raising concerns about CEO Sam Altman's leadership in 2023. When the board ousted Altman in November of that year, Murati served as interim CEO before Altman was quickly reinstated.

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis
Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

Yahoo

timean hour ago

  • Yahoo

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 biotech stocks screaming a buy. On June 17, the company delivered positive trial results from a preclinical study of ZL-1503, a promising IL-13/IL-31R bispecific antibody. Chemists in a laboratory studying beakers of liquid as they work to develop biopharmaceuticals for chronic inflammation and asthma. In the study, the IL-13/IL-31R bispecific antibody demonstrated the ability to suppress the inflammatory and pruritogenic (itch-causing) pathways in atopic dermatitis (AD). The trial results underscore the potential of ZL-1503 to act as a novel treatment option for moderate-to-severe AD. Some key findings include a single dose of ZL-1503 (10 mg/kg, iv) completely inhibiting IL-13-mediated pSTAT6 and IL-31-induced scratching for at least 76 days. In addition, two out of three subjects exhibited prolonged IL-13-mediated pSTAT6 inhibition over 118 days. Following the positive preclinical study, Zai Lab plans to file an IND for ZL-1503 for moderate-to-severe atopic dermatitis by the end of the year. Zai Lab Limited (NASDAQ:ZLAB) is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in oncology, immunology, neuroscience, and infectious disease. While we acknowledge the potential of ZLAB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store